Medium materiality6/10
Goldman Sachs reiterates Buy on Xylem
Why it may matterVerify against the original reporting
The reiterated Buy and large target-to-price gap are supportive, but an analyst target is an opinion rather than a guaranteed return.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs reiterated its Buy rating on Xylem and set a $138 target versus a posted price of $92.86. The stock is down 0.5% since the signal.
- Goldman Sachs Buy rating reiterated; target: $138 vs. posted price: $92.86.
- Price change since signal: -0.5%.
Key facts
- 01
Target: $138
- 02
Posted price: $92.86
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Brian Lee
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.